$MDGL 's Rezdiffra is prescribed mostly for patients with early and moderate MASH.
$ETNB is developing a drug similar to $AKRO. Stock up 66% pre market.
www.statnews.com/2025/01/27/a...
$MDGL 's Rezdiffra is prescribed mostly for patients with early and moderate MASH.
$ETNB is developing a drug similar to $AKRO. Stock up 66% pre market.
www.statnews.com/2025/01/27/a...